- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Mo | GT Medical secures expanded GammaTile clearance in newly diagnosed brain tumors | ||
| Mo | Flagship's Ohana Biosciences debuts with sperm-focused fertility platform | ||
| Mo | Parkinson's discovery could yield new treatment strategy for young onset patients | ||
| Mo | Tilt Biotherapeutics, Biotheus team up on tumor-targeting virus | ||
| Mo | GSK hands TB vaccine to Gates Foundation's nonprofit biotech | ||
| Mo | J&J jumping in on coronavirus vax work as disease continues its spread | ||
| Mo | Allergan axes AstraZeneca deal, clearing path for AbbVie merger | ||
| Mo | Verily nets irregular pulse clearance for its clinical study smartwatch | ||
| Mo | Quench Bio emerges with $50M to treat severe inflammatory disease | ||
| Sa | FDA warns of cybersecurity gaps in GE Healthcare's patient monitors | ||
| Fr | Smith & Nephew picks up Tusker Medical and its in-office ear tube treatment | ||
| Fr | Summit Therapeutics loses R&D president after BARDA funding boost | ||
| Fr | Has home DNA testing hit its high-water mark? 23andMe to lay off 100 as sales turn: CNBC | ||
| Fr | PwC report sees pharma-biotech deals 'to be extremely active in 2020' | ||
| Fr | Drug 'chaperone' fends off Alzheimer's in mice by preventing toxic protein clumping | ||
| Fr | ATAI, DemeRx pursue 'neurochemical reset' for addiction in $22M JV | ||
| Fr | Chutes & Ladders-Lonza seeking experience in CEO successor | ||
| Fr | Gilead mulls repositioning failed Ebola drug in China virus | ||
| Fr | Repurposing non-oncology drugs to treat cancer | ||
| Fr | Ipsen's $1B bet on the ropes after interim phase 3 analysis | ||
| Do | Deloitte, Rady Children's to launch medical drone delivery program to beat San Diego traffic | ||
| Do | In conversation with Myrtle Potter, CEO of Sumitovant | ||
| Do | FDA approves Medtronic's tiny, wireless, minimally invasive pacemaker implant | ||
| Do | Summit Therapeutics tops up C. diff war chest with $8.8M BARDA funding | ||
| Do | EuroBiotech Report-Roche SMA data, iOnctura, PDC*line, Targovax and Bayer |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
